National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care

Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise and inconsistent diagnostic coding can fragment care and delay accurate identification. Standardized capture of genetic and phenotypic data remains a persistent gap for coordinated management across regions. A new study details the development of a national quality registry designed to address these gaps.

Lund University, working with Sweden’s National Programme Area for Rare Diseases, is leading RaraSwed, a national rare disease quality registry being implemented across the Swedish health care system. The platform consolidates structured information on molecular genetic diagnosis, diagnostic coding, clinical symptoms, genetic findings, disease progression, and treatment. Its architecture is modular: a diagnostic module launched in September 2023, a patient-reported data module is underway, and a physician-reported data module is planned.

RaraSwed is designed to standardize shared variables across heterogeneous rare conditions, enabling consistent nomenclature and comparable records. By aggregating longitudinal clinical and genetic data, the registry supports development of national clinical guidelines and evidence-based decision-making at the point of care. The dataset is intended for both research use and continuous quality improvement within Sweden’s knowledge-driven health system.

The study describing development and national implementation is presented as a Health Policy perspective and focuses on methods to extract homogeneous data elements from disease groups that vary widely in presentation. Researchers identify significant structural challenges, including variations in medical records and information technology (IT) infrastructure across Swedish health care regions. Additional barriers include data interoperability and sharing when regions apply differing legislative interpretations to patient information.

Early implementation indicates variation in reporting practices between regions, with differences that may reflect documentation workflows or the availability of genetic testing capacity. Stakeholders can monitor regional reporting in real time via the Centre for Rare Diseases, supporting transparency as the registry scales. The authors position the registry as a key instrument for more equitable, accessible rare disease care across Sweden. The work was published in BMC Global and Public Health on June 16, 2026, with contributions from Lund University, Skåne University Hospital, Swedish health care regions, and the Centre for Rare Diseases.

“Digital health and data-driven medicine are global priorities. Our study demonstrates that a well-designed registry can transform fragmented data into actionable knowledge that benefits both the Swedish and international medical communities. This enables a more efficient, equitable health care system and ultimately improves care coordination for people living with rare diseases,” said Sanna Mansoob, doctoral student at Lund University and resident physician in pediatrics at Skåne University Hospital.

Related Links
Lund University